Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and Esketamine for CRBD
NCT06399185Phase 4Recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jun 2024
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine, esketamine in cystitis, sponsored by Peking University First Hospital. Started Jun 2024; status: recruiting.
02
Drugs
dexmedetomidineesketamine
03
Conditions
cystitis
Beyond the preview
Go deeper on NCT06399185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06399185.